The present invention provides compositions including siderophore receptor polypeptides from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods o
The present invention provides compositions including siderophore receptor polypeptides from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions.
대표청구항▼
1. A composition comprising: at least two siderophore receptor polypeptides (SRPs) isolated from a gram negative microbe; andlipopolysaccharide (LPS) at a concentration of no greater than about 10.0 endotoxin units per milliliter (EU/ml). 2. The composition of claim 1 further comprising a pharmaceut
1. A composition comprising: at least two siderophore receptor polypeptides (SRPs) isolated from a gram negative microbe; andlipopolysaccharide (LPS) at a concentration of no greater than about 10.0 endotoxin units per milliliter (EU/ml). 2. The composition of claim 1 further comprising a pharmaceutically acceptable carrier. 3. The composition of claim 1 wherein the gram negative microbe is an enteropathogen. 4. The composition of claim 1 wherein the gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae. 5. The composition of claim 1 wherein the gram negative microbe is a member of the tribe Escherichieae or Salmonelleae. 6. The composition of claim 1 wherein the gram negative microbe is Salmonella spp., Escherichia coli , Actinobacillus spp., Haemophilus spp., or Campylobacter spp. 7. The composition of claim 1 wherein the at least two SRPs have molecular weights of between about 60 kDa and about 100 kDa as determined by separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 8. The composition of claim 1 further comprising at least one porin having a molecular weight of between about 30 kDa and about 43 kDa as determined by separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 9. A siderophore receptor polypeptide (SRP) composition comprising: at least two SRPs isolated from a gram negative microbe; andlipopolysaccharide (LPS) at a concentration of no greater than the concentration of LPS in a reference composition comprising: the at least two siderophore receptor polypeptides isolated from the gram negative microbe and lipopolysaccharide; wherein the reference composition is produced by a process comprising: providing the gram negative microbe;disrupting the gram negative microbe in a buffer;solubilizing the disrupted gram negative microbe for greater than about 24 hours in a solution comprising sarcosine to result in solubilized and insoluble cellular material, wherein a ratio of the sarcosine to gram weight of disrupted gram negative microbe is between about 0.8 gram sarcosine per about 4.5 grams of disrupted gram negative microbe and about 1.2 grams sarcosine per about 4.5 grams of disrupted gram negative microbe; andisolating molecules of the gram negative microbe, wherein the isolated molecules comprise the at least two SRPs and LPS. 10. The SRP composition of claim 9 further comprising a pharmaceutically acceptable carrier. 11. The SRP composition of claim 9 wherein the gram negative microbe is an enteropathogen. 12. The SRP composition of claim 9 wherein the gram negative microbe is a member of the family Enterobacteriaceae, family Vibrionaceae, family Pasteurellaceae, or family Pseudomonadaceae. 13. The SRP composition of claim 9 wherein the gram negative microbe is a member of the tribe Escherichieae or Salmonelleae. 14. The SRP composition of claim 9 wherein the gram negative microbe is Salmonella spp., Escherichia coli, Actinobacillus spp., Haemophilus spp., or Campylobacter spp. 15. The SRP composition of claim 9 wherein the at least two SRPs have molecular weights of between about 60 kDa and about 100 kDa as determined by sodium dodecyl-polyacrylamide gel electrophoresis. 16. The SRP composition of claim 9 further comprising at least one porin having a molecular weight of between about 30 kDa and about 43 kDa as determined by sodium dodecyl-polyacrylamide gel electrophoresis. 17. The composition of claim 1 wherein the concentration of LPS is determined by a gel-clot test comprising a Limulus amebocyte lysate. 18. The composition of claim 17 wherein the gel-clot test comprises contacting the composition with a lysate of horseshoe crab circulating amebocytes to form a mixture, wherein the pH of the composition is between 6 and 8, incubating the mixture for about 1 hour at about 37° C., and determining if there is gelation, wherein gelation indicates the presence of LPS. 19. The composition of claim 9 wherein the concentration of LPS is determined by a gel-clot test comprising a Limulus amebocyte lysate. 20. The composition of claim 19 wherein the gel-clot test comprises contacting the composition with a lysate of horseshoe crab circulating amebocytes to form a mixture, wherein the pH of the composition is between 6 and 8, incubating the mixture for about 1 hour at about 37° C., and determining if there is gelation, wherein gelation indicates the presence of LPS. 21. The composition of claim 4 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., Yersinia spp., Myxcobacteria spp., Sporocytophaga spp., Chondrococcus spp., Cytophaga spp., Flexibacter spp., Flavobacterium spp., or Aeromonas spp. 22. The composition of claim 4 wherein the member of the family Vibrionaceae is Vibrio cholerae. 23. The composition of claim 4 wherein the member of the family Pasteurellaceae is Pasturella spp. 24. The composition of claim 23 wherein the Pasturella spp. is Pasturella multocida or Pasteurella haemolytica. 25. The composition of claim 4 wherein the member of the family Pseudomonadaceae is Pseudomonas spp. 26. The composition of claim 25 wherein the Pseudomonas spp. is Pseudomonas aeruginosa. 27. The composition of claim 12 wherein the member of the family Enterobacteriaceae is Shigella spp., Proteus spp., Klebsiella spp., Serratia spp., Yersinia spp., Myxcobacteria spp., Sporocytophaga spp., Chondrococcus spp., Cytophaga spp., Flexibacter spp., Flavobacterium spp., or Aeromonas spp. 28. The composition of claim 12 wherein the member of the family Vibrionaceae is Vibrio cholerae. 29. The composition of claim 12 wherein the member of the family Pasteurellaceae is Pasturella spp. 30. The composition of claim 29 wherein the Pasturella spp. is Pasturella multocida or Pasteurella haemolytica. 31. The composition of claim 12 wherein the member of the family Pseudomonadaceae is Pseudomonas spp. 32. The composition of claim 31 wherein the Pseudomonas spp. is Pseudomonas aeruginosa.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (42)
Daryll A. Emery ; Darren E. Straub ; Richard Huisinga ; Beth A. Carlson, Active immunization using a siderophore receptor protein.
Potter Andrew A. (Saskatoon CAX) Harland Richard J. (Saskatoon CAX), Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins.
Schryvers Anthony B. (Calgary CAX), Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of va.
Blake Milan S. (New York NY) Tai Joseph Y. (Fort Washington PA) Qi Huilin L. (New York NY) Liang Shu-Mei (Bethesda MD) Hronowski Lucjan J. J. (Laurel MD) Pullen Jeffrey K. (Columbia MD), Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Ne.
Emery Daryll A. (Willmar MN) Straub Darren E. (Willmar MN) Huisinga Richard (Willmar MN), Method of priming an immune response in a one-day old animal.
Emery,Daryll A.; Straub,Darren E.; Zammert,Donavan E.; Kallevig,Gayla K., Methods for making compositions including gram negative microbial polypeptides.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Tam, Patricia E.; Harris, Michael Nathan; Tripp, Timothy James; Lobo, Sandra, Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Herron-Olson, Lisa L.; Wonderling, Laura, Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Herron-Olson, Lisa L.; Wonderling, Laura, Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Herron-Olson, Lisa L.; Wonderling, Laura, Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
Emery, Daryll A.; Straub, Darren E.; Wonderling, Laura; Herron Olson, Lisa L., Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.